Shiv Shah retweetledi
Happy #FellowMatch day! We look forward to welcoming 18 hematology/oncology fellows to @MSKCancerCenter next summer to continue our legacy of providing outstanding #cancer care. #Match2026
English
Shiv Shah
210 posts
Shiv Shah
@shivemshah
MD/PhD the scenic way: now @ColumbiaPS | PhD ‘20 @CornellBME | @BUalumni. Immunoengineer, #organoids, #antibodies, #lymphoma. NY sports stan. #FGLI. he/him
Washington Heights, NY Katılım Aralık 2016
891 Takip Edilen376 Takipçiler
English
@Dr_ASingh @shivemshah @Columbia @WeillCornell @MSKCancerCenter @ColumbiaPS Congrats to @shivemshah!!
English
So thankful for @Dr_ASingh and my mentors to help me get one step closer to my dream of becoming an oncologist :)
Ankur Singh@Dr_ASingh
Greatly satisfying to see the success of trainees! @shivemshah, former 💫PhD, completed his MD @Columbia in what we call “Shiv’s style”- winning the “Janeway Prize” 🏆for highest achievements!Passionate for oncology, Shiv is now @WeillCornell before he starts @MSKCancerCenter! 🙌🏽
English
Shiv Shah retweetledi
I am very happy to share our recent preprint led by @miguelib93 from @uniklinik_hd and @lcaprio412 from @BizarMd group @columbiacancer.
Here, we have developed a novel machine learning tool called #micronuclAI which enables automatic quantification of chromosomal instability via micronuclei detection.
Learn more here: doi.org/10.1101/2024.0…
English
Shiv Shah retweetledi
Happy to see this paper out! Congrats to the lab, especially MD/PhD student par excellence @zwalsh96
Nature Biotechnology@NatureBiotech
Mapping variant effects on anti-tumor hallmarks of primary human T cells with base-editing screens go.nature.com/3yxjW7q
English
Shiv Shah retweetledi
Very happy to share some of my PhD work, published yesterday in @NatureBiotech. Especially thankful for truly exceptional mentorship from my PI, @BizarMd, who encouraged me to leverage powerful gene editing tools to ask some exciting questions bridging immunology and genetics
Nature Biotechnology@NatureBiotech
Mapping variant effects on anti-tumor hallmarks of primary human T cells with base-editing screens go.nature.com/3yxjW7q
English
in my PhD, I worked at WCMC seeing pts & building collabs, which affirmed my decision to pursue heme/onc. thru this exp and working with pts @CancerResource, I dreamed of being at WCMC/MSK. altho my path was atypical, it's surreal how this dream is now coming full circle
English
Excited to continue my oncologist physician-scientist journey at my top choice @WeillCornell through their IM medical research track in which I matched IM at Weill and heme/onc fellowship at my choice of @MSKCancerCenter or @WCMHemOncFellow #Match2024
English
Life update: I’m FINALLY done with school, and officially ~Shivem (Shiv) Shah, MD PhD~ Infinitely grateful to my partner, dog, friends, family, clinical & research mentors, and patients for shaping me into the person I am today. #MedGrad #MedTwitter #FGLI
English
Shiv Shah retweetledi
I am delighted to share the newest work from the @SternbergLab, in which we discover RNA-templated gene creation as a mechanism of antiviral immunity. This is a story for anyone who loves molecular biology, and one that repeatedly left us in disbelief. doi.org/10.1101/2024.0…
English
Shiv Shah retweetledi
Programming of naïve T cells for superior adoptive T-cell therapy!! Thrilled to share our work @ Nature Nanotechnology @NatureNano! Great collab w/ Brian Rudd & Andrew Grimson. Kudos to 1st authors Kristel & Sungwoong, & Zhonghao!! Congrats to all authors! nature.com/articles/s4156…
English
Shiv Shah retweetledi
Very excited to share new work from the lab dissecting mechanisms of liver-metastatic organotropism in melanoma and other cancers. Huge congrats to fearless post-doc @meri_rogava (on the job market!) who led this multi-year study! Below a brief summary...
nature.com/articles/s4301…
English
Shiv Shah retweetledi
A privilege to work with and learn from the late Filippo @Giancotti_Lab and @DhirajKumar9906 among many others. This work contributes to the great legacy of Filippo, one of the most rigorous cancer cell biologists in the world.
nature.com/articles/s4301…
English
Shiv Shah retweetledi
💫NEW CONTENT @NatureCancer “LncRNA Malat1 suppresses pyroptosis and T cell-mediated killing of incipient metastatic cells” by @BizarMd #DhirajKumar the late #FilippoGiancotti @Giancotti_Lab & Co.
Read it here👇
nature.com/articles/s4301…
rdcu.be/dvEPx
English
Shiv Shah retweetledi
Very happy to share our preprint on pooled base editing in primary human T cells to discover genetic variants modulating T cell function. Incredible effort by MD/PhD student @zwalsh96 and other members of the @BizarMd lab at @Columbia.
bizarMD@BizarMd
Interested in T cell biology? Cellular immunotherapies? Base editing? And an amazing example for scientific reproducibility- this @biorxivpreprint & tweetorial are for you! TL:DR- we made primary human T cells better cancer killers! biorxiv.org/content/10.110…
English
Shiv Shah retweetledi
Excited to share our new preprint! We developed methods for - and executed - pooled base editor screens of >100 critical T cell signaling genes in primary human T cells. We leveraged our findings to characterize critical protein domains and engineer superior anti-tumor T cells!
bizarMD@BizarMd
Interested in T cell biology? Cellular immunotherapies? Base editing? And an amazing example for scientific reproducibility- this @biorxivpreprint & tweetorial are for you! TL:DR- we made primary human T cells better cancer killers! biorxiv.org/content/10.110…
English
SO excited to see this work led by @zwalsh96 and Parin and co-supervised by @JCA_Melms and @BizarMd finally out in the world. Science beautifully summarized below ⬇️, but I wanted to talk a little more about the secret sauce behind the paper and hand out 💐 #AcademicChatter
bizarMD@BizarMd
Interested in T cell biology? Cellular immunotherapies? Base editing? And an amazing example for scientific reproducibility- this @biorxivpreprint & tweetorial are for you! TL:DR- we made primary human T cells better cancer killers! biorxiv.org/content/10.110…
English